Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Telomerase: prudence! prudence!]

C J Larsen

    Bulletin Du Cancer
    |February 24, 2001
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [A mutation suppressing a sumoylation site in the MITF transcriptional regulator predisposes to melanoma and renal carcinoma].

    Bulletin du cancer·2012
    Same author

    The status of CDKN2A alpha (p16INK4A) and beta (p14ARF) transcripts in thyroid tumour progression.

    British journal of cancer·2006
    Same author

    Expression of TAp73 and DeltaNp73 isoform transcripts in thyroid tumours.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2005
    Same author

    Correlation of clinical features and methylation status of MGMT gene promoter in glioblastomas.

    Journal of neuro-oncology·2004
    Same author

    Topoisomerase II alpha and telomerase expression in papillary thyroid carcinomas.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2004
    Same author

    [Clearing up the p16INK4a-p14/p19ARF imbroglio?].

    Bulletin du cancer·2001
    Same journal

    [ONCONNECTE À L'EMPLOI, feedback after three years of a program to prepare for returning to work after cancer in Franche-Comté].

    Bulletin du cancer·2026
    Same journal

    [Off-label use of venetoclax in myeloma].

    Bulletin du cancer·2026
    Same journal

    [Cemiplimab - Adjuvant treatment for the cutaneous squamous cell carcinomas with high risk of relapse, operated and treated by radiotherapy].

    Bulletin du cancer·2026
    Same journal

    Real-world outcomes and management of endometrial cancer in France from 2016 to 2021 (MOONBEAM study).

    Bulletin du cancer·2026
    Same journal

    [Cardiotoxicity in children and adolescents with acute leukemia: Recommendations from the Leukemia Committee of the French Society of Childhood Cancer (SFCE)].

    Bulletin du cancer·2026
    Same journal

    [Reirradiation: A new therapeutic paradigm in oncology].

    Bulletin du cancer·2026
    See all related articles